Enhancing Quality Oversight in Pharmaceutical Contract Manufacturing Organizations: Master CMO Quality Oversight in Pharma with Online Training Seminar
26 oct. 2023 12h43 HE
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Enhancing Quality Oversight in Pharmaceutical Contract Manufacturing Organizations" training course has been added to ResearchAndMarkets.com's...
Pharmaceutical Continuous Manufacturing: Revolutionizing Drug Production for Efficiency and Quality
26 oct. 2023 08h18 HE
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added...
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
17 oct. 2023 08h05 HE
|
Avid Bioservices, Inc
Avid completes construction of cell and gene theapy facility bringing total revenue generating capacity to up to ~$400 Million annually
[With 9.5% CAGR] Biologics Contract Manufacturing Market to Observe Strong Growth During 2023-2030, According to RationalStat Analysis and Market Report
13 oct. 2023 04h29 HE
|
Rationalstat LLC
Wilmington, Delaware, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Global Biologics Contract Manufacturing Market value is estimated at US$ 15.5 billion in 2023 and is expected to grow at a significant CAGR of...
Societal CDMO Reports Inducement Grants for New Staff
05 oct. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
26 sept. 2023 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Societal CDMO to Participate in RBC Capital Markets Virtual CDMO Conference
25 sept. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO)...
Pharmaceutical Contract Manufacturing Market Projected to Reach $222 Billion by 2028, Driven by Growing Demand for Generic and Specialty Medicines
25 sept. 2023 09h33 HE
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ...
Societal CDMO Announces Corporate Restructuring
20 sept. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Global Pharmaceuticals and Biotechnology Manufacturing and Supply Deals Analysis Report and Directory 2023
18 sept. 2023 07h28 HE
|
Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2023" report has been added to ResearchAndMarkets.com's...